BeyondSpring Inc

BYSINASDAQ · USD
0.71USD0.00 (0.00%)
112

BeyondSpring Inc (BYSI) Expected Move

BYSI expected move through Sep 18, 2026 is 485.9%, with 0 days to expiration. The implied range is -$2.74 to $4.16, based on the previous trading day's options prices.

Read more

Tracking the BYSI expected move helps you see how far BeyondSpring Inc's options market is pricing the stock to travel over a given period — whether that's the next day, week, or earnings cycle. BeyondSpring Inc's expected move is derived directly from option premiums and gives you an objective range to plan trades, set strikes, and manage risk. Use our scanner to monitor the BYSI expected move for this week's options, in real time.

The expected move is typically calculated from at-the-money straddle prices (or a blend of straddles and strangles) and represents roughly a one-standard-deviation range over the chosen timeframe. For BYSI, comparing the implied expected move to actual realized moves over similar windows tells you whether the options market has historically overestimated or underestimated volatility. The BYSI expected move for this week's options pricing is especially useful for short-dated traders, earnings players, and anyone selling premium who needs to know where the market thinks BeyondSpring Inc is unlikely to go.

BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer. It is also developing Plinabulin in combination with various immuno-oncology agents, including nivolumab, a PD-1 antibody for the treatment of NSCLC; nivolumab and ipilimumab, a CTLA-4 antibody for the treatment of SCLC; and in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers.

In addition, the company engages in the development of three small molecule immune agents in preclinical stages; and a drug development platform. The company was founded in 2010 and is headquartered in New York, New York.

Iron condors, weekly premium sales, directional swing trades — they all live or die by where the market thinks the stock won't go. Our scanner tracks the BYSI expected move across every expiration, benchmarks it against realized moves, and shows you when implied ranges are out of line with history. The BeyondSpring Inc expected move for this week's options is the fastest read on short-term risk, which gives you a quick way to interpret what the options market thinks about BYSI.

BYSI Price

EARN
EM

Drag chart to pan. Drag axes to zoom.

ExpirationDTEExpected move (USD)Expected move (%)Upper priceLower price
Sep 18, 20260$3.45485.9%$4.16-$2.74
Oct 16, 202628$3.33468.3%$4.04-$2.62
Nov 20, 202663$3.85542.3%$4.56-$3.14
Jan 15, 2027119$3.59505.3%$4.30-$2.88

As of September 17, 2026

Know What the Market Expects From BYSI

Track the BYSI expected move across every expiration, filter by IV rank and liquidity, and trade around the range the market is already pricing in.

Start your 14-day free trial